Ciencias Económicas y Empresariales
Fakultatea
National University of Singapore
Singapur, SingapurNational University of Singapore-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2016
-
Phase 1B/2 study of the HSP90 inhibitor AUY922 plus trastuzumab in metastatic HER2-positive breast cancer patients who have progressed on trastuzumab-based regimen
Oncotarget, Vol. 7, Núm. 25, pp. 37680-37692